Enzo Biochem, Inc. (ENZ) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1153779,
    "name": "Enzo Biochem, Inc.",
    "stock_name": "Enzo Biochem, Inc.",
    "full_name": "Enzo Biochem, Inc.",
    "name_url": "stocks-analysis/enzo-biochem-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.70",
    "chg": 0.01,
    "chgp": "1.66%",
    "dir": 1,
    "prev_price": "0.69",
    "mcapval": "36.59",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US2941001024",
    "curr_date": "Aug 19",
    "curr_time": "",
    "bse_nse_vol": "723.5 k",
    "exc_status": "Active",
    "traded_date": "Aug 19, 2025",
    "traded_date_str": "2025 08 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/enzo-biochem-inc-1153779-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Enzo Biochem, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-enzo-biochem-inc-technically-bullish-or-bearish-3545035",
        "imagepath": "",
        "date": "2025-09-20 19:02:04",
        "description": "As of 1 July 2025, the technical trend for Enzo Biochem, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The daily moving averages indicate a mildly bearish trend, while the weekly RSI is bearish. The MACD shows bullish momentum on the weekly but is mildly bullish on the monthly, suggesting mixed signals. The Bollinger Bands are bullish weekly but mildly bearish monthly, and the KST is bullish weekly but bearish monthly. \n\nIn terms of performance, Enzo Biochem has underperformed significantly against the S&P 500 over the longer term, with a 1-year return of -37.60% compared to the S&P 500's 17.14%, and a 5-year return of -70.39% versus 96.61% for the index...."
      },
      {
        "title": "Is Enzo Biochem, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-enzo-biochem-inc-overvalued-or-undervalued-3541755",
        "imagepath": "",
        "date": "2025-09-20 17:35:19",
        "description": "As of 9 June 2022, the valuation grade for Enzo Biochem, Inc. moved from fair to risky, indicating a deterioration in its financial outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.67 and an EV to EBITDA ratio of 1.12, which suggests that the market may not be accurately pricing in the challenges faced by the company. Additionally, the negative ROE of -12.03% further underscores the financial difficulties.\n\nIn comparison to its peers, Enzo Biochem, Inc. has a significantly lower EV to EBITDA ratio than BioAtla, Inc. at -0.2934, highlighting its underperformance within the industry. Furthermore, the company's stock has underperformed against the S&P 500 over multiple periods, with a YTD return of -2.16% compared to the S&P 500's 12.22%, and a staggering 5Y return of -70.39% against the S&P's 96.61%. This trend reinforces the notion that Enz..."
      }
    ],
    "total": 7,
    "sid": "1153779",
    "stock_news_url": "https://www.marketsmojo.com/news/enzo-biochem-inc-1153779"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Enzo Biochem, Inc. technically bullish or bearish?

2025-09-20 19:02:04

As of 1 July 2025, the technical trend for Enzo Biochem, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The daily moving averages indicate a mildly bearish trend, while the weekly RSI is bearish. The MACD shows bullish momentum on the weekly but is mildly bullish on the monthly, suggesting mixed signals. The Bollinger Bands are bullish weekly but mildly bearish monthly, and the KST is bullish weekly but bearish monthly. In terms of performance, Enzo Biochem has underperformed significantly against the S&P 500 over the longer term, with a 1-year return of -37.60% compared to the S&P 500's 17.14%, and a 5-year return of -70.39% versus 96.61% for the index....

Is Enzo Biochem, Inc. overvalued or undervalued?

2025-09-20 17:35:19

As of 9 June 2022, the valuation grade for Enzo Biochem, Inc. moved from fair to risky, indicating a deterioration in its financial outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.67 and an EV to EBITDA ratio of 1.12, which suggests that the market may not be accurately pricing in the challenges faced by the company. Additionally, the negative ROE of -12.03% further underscores the financial difficulties. In comparison to its peers, Enzo Biochem, Inc. has a significantly lower EV to EBITDA ratio than BioAtla, Inc. at -0.2934, highlighting its underperformance within the industry. Furthermore, the company's stock has underperformed against the S&P 500 over multiple periods, with a YTD return of -2.16% compared to the S&P 500's 12.22%, and a staggering 5Y return of -70.39% against the S&P's 96.61%. This trend reinforces the notion that Enz...

View All News